Psychological and cognitive function: Predictors of adherence with cholesterol lowering treatment
Background: Failure to adhere to medication regimes is a significant problem in clinical and research settings yet reliable, consistent identification of key psychosocial predictors remains elusive. Studies of mood and personality related to adherence show mixed results—compliance and objectively measured cognitive function are intuitively related but empirical support is lacking.Purpose: This study is a secondary analysis to examine the relations between adherence with a medication regime for lowering serum cholesterol and several domains of psychological and cognitive functioning.Methods: Participants in the initial study completed a measure of personality and a battery of neuropsychological measures at baseline; anxiety and depression were measured at baseline and at 4-week intervals. Medication adherence was tracked with electronic cap monitors for 24 weeks.Results: Only 23% of the sample was fully adherent to medication regimes at least 80% of the time over the 6-month study period. Conscientiousness, according to the Five Factor Theory of Personality, and estimated IQ remained robust predictors of adherence in hierarchical regression analyses. Depression and anxiety, mental flexibility, and visuospatial-constructional ability were less robust but statistically significant (p < .05) correlates of adherence.Conclusions: Although results of this analysis explain only a portion of the variance in adherence, they demonstrate the importance of trait psychological and cognitive factors in adherence research.
Unable to display preview. Download preview PDF.
- (1).Dunbar-Jacob J, Sereika S, Rohay JM, Burke LE, Kwoh CK:Predictors of adherence: Differences by measurement method. 16th Annual Scientific Sessions of the Society of Behavioral Medicine. San Diego, CA: 1995.Google Scholar
- (14).Park DC, Hertzog C, Leventhal H, et al.: Medication adherence in rheumatoid arthritis: Older is wiser.Journal of the American Geriatric Society. 1999,47:172–183.Google Scholar
- (17).Spielberger CD:Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1983.Google Scholar
- (18).Costa PT, McCrae RR:NEO-PI-R Professional Manual. Odessa, FL: Psychological Assessment Resources, 1992.Google Scholar
- (19).Sattler JM:Assessment of Children (3rd ed.). San Diego, CA: Sattler, 1988.Google Scholar
- (20).Wechsler D:Wechsler Adult Intelligence Scale (3rd ed.). New York: Psychological Corporation, 1997.Google Scholar
- (21).Jarvis PE, Barth JT:The Halstead-Reitan Neuropsychological Battery: A Guide to Interpretation and Clinical Applications. Odessa, FL: Psychological Assessment Resources, 1994.Google Scholar
- (22).Reitan RM, Wolfson D:The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neurospsychology Press, 1988.Google Scholar
- (23).Spreen O, Strauss E (eds):A Compendium of Neuropsychological Tests (2nd ed). New York: Oxford University Press, 1988.Google Scholar
- (27).Bartlett JA: Addressing the challenges of adherence.Journal of Acquired Immune Deficiency Syndromes. 2002,29(S1):S2–10.Google Scholar
- (28).Dunbar-Jacob JM, Schlenk EA, Burke LE, Matthews JT: Predictors of patient adherence: Patient characteristics. In Schumaker SA, Schron EB, Ockene JK, McBee WL (eds),The Handbook of Health Behavior Change (2nd ed). New York: Springer, 1998, 491–511.Google Scholar